It’s been little more than over a year since the WHO officially declared the coronavirus outbreak a pandemic.

A safe and effective vaccine portfolio is considered our best bet to overcome the pandemic and while vaccine development is a complex process that could take around 10 years to complete, within just a year into the pandemic, four vaccines against covid-19 have been authorized for use in the EU following the scientific recommendations by the European Medicines Agency.

The EU Vaccines Strategy created by The European Commission states that "under its vaccines strategy, the Commission has forged agreements with individual vaccine producers on behalf of EU countries. Once available, proven safe and effective, and authorized at EU level, all Member States will have access to COVID-19 vaccines at the same time and the distribution will be done on a per capita basis to ensure fair access."

However due to delays in deliveries, skepticism about side-effects, the complexity of coordination amongst national governments, and criticism towards the long and limiting bureaucracy within the EU, the vaccination campaign promptly came under fire. Some EU countries even began talks separately with the main pharma companies to score jabs on their own.

What lessons can we take away from this situation? Why isn't the EU Vaccination Strategy working as originally planned and why is it lagging behind? Why are some countries within the EU going significantly faster than others if there is a common strategy created by Brussels?

Join us in this online panel with our top faculty members where we will discuss what we've learned so far in the EU vaccination strategy that was originally designed to be a landmark in European solidarity.

We hope you can join us!